Clinical Trial Update: Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC） [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dalpiciclib in combination with an aromatase inhibitor as neoadjuvant therapy for early breast cancer. The trial compares this regimen …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Dalpiciclib (dalpiciclib)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING